For: | Yehualashet AS, Yikna BB. Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System. Diabetes Metab Syndr Obes 2021;14:1841-54. [PMID: 33953584 DOI: 10.2147/DMSO.S304497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Dable-tupas G. Phytosynthesized nanomaterials for diabetes treatment. Emerging Phytosynthesized Nanomaterials for Biomedical Applications 2023. [DOI: 10.1016/b978-0-12-824373-2.00004-0] [Reference Citation Analysis] |
2 | Hua X, Feng H. Changes in intestinal microbiota of HBV-associated liver cirrhosis with/without hepatic encephalopathy. Medicine (Baltimore) 2022;101:e29935. [PMID: 35984175 DOI: 10.1097/MD.0000000000029935] [Reference Citation Analysis] |
3 | Thakur PS, Aggarwal D, Takkar B, Shivaji S, Das T. Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy. Invest Ophthalmol Vis Sci 2022;63:21. [PMID: 35877085 DOI: 10.1167/iovs.63.8.21] [Reference Citation Analysis] |
4 | Chen D, Fulcher J, Scott ES, Jenkins AJ. Precision Medicine Approaches for Management of Type 2 Diabetes. Precision Medicine in Diabetes 2022. [DOI: 10.1007/978-3-030-98927-9_1] [Reference Citation Analysis] |